49 2 Macrophage Metabolic Reprogramming in Diabetes REFERENCES 1. Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes [Accessed May 4, 2021] 2. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract (2017) 128:40–50. doi: 10.1016/j.diabres.2017.03.024 3. Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes (2019) 43:139–148. doi: 10.1038/s41366-018-0076-3 4. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature (2017) 542:177–185. doi: 10.1038/nature21363 5. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. Journal of Clinical Investigation (2005) 115:1111–1119. doi: 10.1172/jci25102 6. Franssens BT, Westerink J, van der Graaf Y, Nathoe HM, Visseren FLJ. Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes. Int J Cardiol (2016)72–77. doi: 10.1016/j. ijcard.2016.07.081 7. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 11:723–737. doi: 10.1038/nri3073 8. Galli G, Saleh M. Immunometabolism of Macrophages in Bacterial Infections. Front Cell Infect Microbiol (2021) 0:903. doi: 10.3389/FCIMB.2020.607650 9. Robbe P, Draijer C, Borg TR, Luinge M, Timens W, Wouters IM, Melgert BN, Hylkema MN. Distinct macrophage phenotypes in allergic and nonallergic lung inflammation. Am J Physiol Lung Cell Mol Physiol (2015) 308:L358–L467. doi: 10.1152/ajplung.00341.2014 10. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation (2003) 112:1796–1808. doi: 10.1172/jci19246 11. Boutens L, Hooiveld GJ, Dhingra S, Cramer RA, Netea MG, Stienstra R. Unique metabolic activation of adipose tissue macrophages in obesity promotes inflammatory responses. Diabetologia 2018 61:4 (2018) 61:942–953. doi: 10.1007/S00125-017-4526-6 12. Freemerman AJ, Johnson AR, Sacks GN, Milner JJ, Kirk EL, Troester MA, Macintyre AN, Goraksha-Hicks P, Rathmell JC, Makowski L. Metabolic reprogramming of macrophages: Glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. Journal of Biological Chemistry (2014) 289:7884–7896. doi: 10.1074/jbc.M113.522037 13. IJsbrand M. Kramer. “Signaling through the Insulin Receptor: Phosphoinositide 3-Kinases and AKT- ClinicalKey.,” Signal Transduction. (2016). p. 849–886 https://www-clinicalkey-com. proxy-ub.rug.nl/#!/content/book/3-s2.0-B9780123948038000164 [Accessed April 17, 2020] 14. Cersosimo E, Triplitt C, Mandarino LJ, DeFronzo RA. Pathogenesis of Type 2 Diabetes Mellitus. (2015) http://www.ncbi.nlm.nih.gov/books/NBK279115/ [Accessed October 20, 2020] 15. Han CY, Kargi AY, Omer M, Chan CK, Wabitsch M, O’Brien KD, Wight TN, Chait A. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: Dissociation of adipocyte hypertrophy from inflammation. Diabetes (2010) 59:386–396. doi: 10.2337/db09-0925
RkJQdWJsaXNoZXIy MTk4NDMw